Gastro-intestinal Manifestations of Graft Versus Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation: A Prospective Study

被引：0
|
作者：
Saoji, Aniket [1 ]
机构：
[1] BI Kapur Mem Hosp, New Delhi, India
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
GVHD; allogenic HSCT; endoscopy; Gastro-intestinal manifestations;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP 0821
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [21] Spectrum of Ocular Disease in Graft Versus Host Disease After Allogenic Hematopoetic Stem Cell Transplantation
    Ghaznawi, N.
    Hammersmith, K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [22] Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease
    Yanagi, Masato
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Kodama, Koya
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [23] Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
    Fryderyk Lorenz
    Stefan Marklund
    Mårten Werner
    Richard Palmqvist
    Björn Engelbrekt Wahlin
    Anders Wahlin
    Scientific Reports, 5
  • [24] Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
    Lorenz, Fryderyk
    Marklund, Stefan
    Werner, Marten
    Palmqvist, Richard
    Wahlin, Bjorn Engelbrekt
    Wahlin, Anders
    SCIENTIFIC REPORTS, 2015, 5
  • [25] Association between acute graft versus host disease and early lung injury after allogenic hematopoietic stem cell transplantation
    Liu, Qifa
    Luo, Xiaodan
    Ning, Juan
    Xu, Dan
    Fan, Zhiping
    Sun, Jing
    Zhang, Yu
    Xu, Bing
    Wei, Yongqian
    BLOOD, 2007, 110 (11) : 318B - 318B
  • [26] Prior Use of Mogamulizumab to Allogenic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-Versus-Host Disease
    Sugio, Takeshi
    Kato, Koji
    Aoki, Takatoshi
    Ota, Takanori
    Saito, Noriyuki
    Yoshida, Shuro
    Kawano, Ichiro
    Henzan, Hideho
    Takase, Ken
    Muta, Tsuyoshi
    Miyawaki, Kohta
    Shima, Takahiro
    Takashima, Shuichiro
    Yamauchi, Takuji
    Mori, Yasuo
    Yoshimoto, Goichi
    Kamezaki, Kenjiro
    Takenaka, Katsuto
    Kamimura, Tomohiko
    Ohno, Yuju
    Eto, Tetsuya
    Ogawa, Ryosuke
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Akashi, Koichi
    BLOOD, 2015, 126 (23)
  • [27] Incidence of acute graft versus host disease in allogenic blood stem cell transplantation.
    Tarantolo, SR
    Bishop, MR
    Cowles, K
    Reed, EC
    Bierman, PJ
    Vose, JM
    MartinAlgarra, S
    Pavletic, ZS
    Nasrati, K
    Armitage, JO
    Kessinger, A
    BLOOD, 1995, 86 (10) : 1562 - 1562
  • [28] PERICARDIAL DISEASE IN PATIENTS WITH GRAFT VERSUS HOST DISEASE AFTER ALLOGENIC STEM CELL TRANSPLANTATION FOR HEMATOPOIETIC MALIGNANCY: AN UNCOMMON BUT CHALLENGING DISEASE FOR THE CLINICIAN
    De Biasio, M.
    Baldassi, M.
    Proclemer, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G179 - G179
  • [29] MANAGING CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF CHRONIC GRAFT VERSUS HOST DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT.
    Kundalia, Ronak
    Hanini, Anas
    Gatewood, Tyra
    Mishra, Asmita
    Pina, Yolanda
    Mokhtari, Sepideh
    NEURO-ONCOLOGY, 2022, 24 : 146 - 146
  • [30] Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant
    Pilar, Fraile
    Lourdes, Vazquez
    Dolores, Caballero
    Pedro, Garcia-Cosmes
    Lucia, Lopez
    Miguel Jesus, San
    Jose Matias, Tabernero
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (02) : 129 - 134
12345